Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Faezeh Tatari, Vahid Farnia, Fatemeh Lalehgni, Asieh Moradi, Farnaz Radmehr, Omran Davarinejad, Sara Hookari, Safora Salemi, Farzaneh Golmohammadi & Mostafa Alikhani. (2022) The efficacy of venlafaxine in the treatment of depression, withdrawal symptoms, and craving in individuals with methamphetamine dependence. Journal of Substance Use 0:0, pages 1-9.
Read now
Read now
Vahid Farnia, Jalal Shakeri, Faezeh Tatari, Toraj AhmadiJuibari, Katayoun Yazdchi & Nasrin Abdoli. (2015) The evaluation of sexual dysfunction among male patients with methamphetamine abuse and withdrawal. Journal of Substance Use 20:5, pages 363-366.
Read now
Read now
Sadmir Ciketic, Mohammad R. Hayatbakhsh, Chris M. Doran, Jake M. Najman & Rebecca McKetin. (2012) A review of psychological and pharmacological treatment options for methamphetamine dependence. Journal of Substance Use 17:4, pages 363-383.
Read now
Read now
Todd Zorick, Rajkumar J Sevak, Karen Miotto, Steven Shoptaw, Aimee-Noelle Swanson, Clayton Clement, Richard De La Garza$suffix/text()$suffix/text(), Thomas F Newton & Edythe D London. (2010) Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. Journal of Experimental Pharmacology 2, pages 13-18.
Read now
Read now
Nady el-Guebaly. (2008) About ISAM: Its Inception and Promises. Substance Abuse 29:3, pages 1-3.
Read now
Read now
Articles from other publishers (85)
Azeem Iqbal, Filip Ložek, Ismael Soto, Davinder Kaur, Kateřina Grabicová, Iryna Kuklina, Tomáš Randák, Viktoriia Malinovska, Miloš Buřič & Pavel Kozák. (2023) Effect of psychoactive substances on cardiac and locomotory activity of juvenile marbled crayfish Procambarus virginalis. Ecotoxicology and Environmental Safety 260, pages 115084.
Crossref
Crossref
Radha Sadacharan & Josiah D. Rich. 2022. Public Health Behind Bars. Public Health Behind Bars
403
416
.
Amy Hauck Newman, Zheng-Xiong Xi & Christian Heidbreder. 2023. Therapeutic Applications of Dopamine D3 Receptor Function. Therapeutic Applications of Dopamine D3 Receptor Function
157
201
.
Pavla Hubená, Pavel Horký, Roman Grabic, Kateřina Grabicová, Karel Douda, Ondřej Slavík & Tomáš Randák. (2021) Prescribed aggression of fishes: Pharmaceuticals modify aggression in environmentally relevant concentrations. Ecotoxicology and Environmental Safety 227, pages 112944.
Crossref
Crossref
Xiang-Hu He, Ewa Galaj, Guo-Hua Bi, Yi He, Briana Hempel, Yan-Lin Wang, Eliot L. Gardner & Zheng-Xiong Xi. (2021) β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms. Frontiers in Pharmacology 12.
Crossref
Crossref
Mahboobeh Hadizadeh-Bazaz, Golamhassan Vaezi, Mehdi khaksari & Vida Hojati. (2021) Curcumin attenuates spatial memory impairment by anti-oxidative, anti-apoptosis, and anti-inflammatory mechanism against methamphetamine neurotoxicity in male Wistar rats: Histological and biochemical changes. NeuroToxicology 84, pages 208-217.
Crossref
Crossref
Fan Liao, Hanxuan Wang, Yuankun Dao, Kai Yuan, Jiazhen Lu, Jie Shi, Ying Han, Suwei Dong & Lin Lu. (2021) Synthesis and biological evaluation of a lipopeptide-based methamphetamine vaccine. Chinese Chemical Letters 32:4, pages 1575-1579.
Crossref
Crossref
Hui Shen, Kai Chen, Rosa Anna M. Marino, Ross A. McDevitt & Zheng-Xiong Xi. (2021) Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice. Pharmacology Biochemistry and Behavior 202, pages 173104.
Crossref
Crossref
Afrah Sepehr, Fereshteh Taheri, Sara Heidarian, Majid Motaghinejad & Sepideh Safari. (2020) Neuroprotective and neuro-survival properties of safinamide against methamphetamine-induced neurodegeneration: Hypothetic possible role of BDNF/TrkB/PGC-1α signaling pathway and mitochondrial uncoupling protein −2(UCP-2). Medical Hypotheses 143, pages 110094.
Crossref
Crossref
Buyun Kim, Jangmi Yun & Byoungduck Park. (2020) Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation. Biomolecules & Therapeutics 28:5, pages 381-388.
Crossref
Crossref
Afrah Sepehr, Majid Motaghinejad, Soomaayeh Heysieattalab & Sepideh Safari. (2020) Minocycline may be useful to prevent or treat methamphetamine-induced neural cell death: Hypothetic role of autophagia and apoptosis signaling pathway. Advanced Biomedical Research 9:1, pages 7.
Crossref
Crossref
Fatemeh Majdi, Fereshteh Taheri, Pegah Salehi, Majid Motaghinejad & Sepideh Safari. (2019) Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-κB signaling. Medical Hypotheses 133, pages 109371.
Crossref
Crossref
Xuan Li, Ian R. Davis, Olivia M. Lofaro, Jianjun Zhang, Raffaello Cimbro & F. Javier Rubio. (2019) Distinct gene alterations between Fos‐expressing striatal and thalamic neurons after withdrawal from methamphetamine self‐administration. Brain and Behavior 9:9.
Crossref
Crossref
Amrit Mann & Chris Wagstaff. (2019) Psychosocial treatment for methamphetamine use and the associated mental health symptoms. Advances in Dual Diagnosis 12:3, pages 132-144.
Crossref
Crossref
MARCELA C. SMID, TORRI D. METZ & ADAM J. GORDON. (2019) Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clinical Obstetrics & Gynecology 62:1, pages 168-184.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Milky Kohno, Laura E. Dennis, Holly McCready, Daniel L. Schwartz, William F. Hoffman & P. Todd Korthuis. (2018) A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder. Drug and Alcohol Dependence 192, pages 186-192.
Crossref
Crossref
Andreas K. Breitbarth, Jody Morgan & Alison L. Jones. (2018) E-cigarettes—An unintended illicit drug delivery system. Drug and Alcohol Dependence 192, pages 98-111.
Crossref
Crossref
Richard S. Schottenfeld, Marek C. Chawarski, Mehmet Sofuoglu, Weng-Tink Chooi, Norzarina M. Zaharim, M. Azhar M. Yasin, Imran Ahmad, Sharifah Zubaidiah Syed Jaapar & B. Kasinather Vicknasingam. (2018) Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial. Drug and Alcohol Dependence 186, pages 130-137.
Crossref
Crossref
Xuan Li, Kailyn R. Witonsky, Olivia M. Lofaro, Felicia Surjono, Jianjun Zhang, Jennifer M. Bossert & Yavin Shaham. (2018) Role of Anterior Intralaminar Nuclei of Thalamus Projections to Dorsomedial Striatum in Incubation of Methamphetamine Craving. The Journal of Neuroscience 38:9, pages 2270-2282.
Crossref
Crossref
Yousef Khani, Hojatoolah Barati, Abolfaz Mollajan, Mahshid Mojtahedzadeh Faghihi & Shahnaz Rimaz. (2018) Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts. International Journal of High Risk Behaviors and Addiction 7:1.
Crossref
Crossref
Kah-Chung Leong, Stewart Cox, Courtney King, Howard Becker & Carmela M. Reichel. 2018. Animal Models for Examining Social Influences on Drug Addiction. Animal Models for Examining Social Influences on Drug Addiction
201
247
.
Tianhua Niu, Jingjing Li, Ju Wang, Jennie Z. Ma & Ming D. Li. (2017) Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes. Frontiers in Psychiatry 8.
Crossref
Crossref
Euphrosyne Gouzoulis-Mayfrank, Roland Härtel-Petri, Willem Hamdorf, Ursula Havemann-Reinecke, Stephan Mühlig & Norbert Wodarz. (2017) Methamphetamine-Related Disorders. Deutsches Ärzteblatt international.
Crossref
Crossref
Major Gooyit, Pedro O. Miranda, Cody J. Wenthur, Alex Ducime & Kim D. Janda. (2016) Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design. ACS Chemical Neuroscience 8:3, pages 468-472.
Crossref
Crossref
Mahdi Rezaei. (2017) Etiology of Changing Pattern of Drug Abuse From Opium to Methamphetamine in Substance Abuser Women: A Qualitative Study. Addictive Disorders & Their Treatment 16:1, pages 20-27.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Nadine Ezard, Adrian Dunlop, Brendan Clifford, Raimondo Bruno, Andrew Carr, Alexandra Bissaker & Nicholas Lintzeris. (2016) Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence. BMC Psychiatry 16:1.
Crossref
Crossref
Erika Pike, William W. Stoops & Craig R. Rush. (2016) Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine. Pharmacology Biochemistry and Behavior 150-151, pages 87-93.
Crossref
Crossref
Sarah J. Baracz & Jennifer L. Cornish. (2016) The neurocircuitry involved in oxytocin modulation of methamphetamine addiction. Frontiers in Neuroendocrinology 43, pages 1-18.
Crossref
Crossref
Allyson L. Spence, Glenn F. Guerin & Nicholas E. Goeders. (2016) The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats. Drug and Alcohol Dependence 166, pages 209-217.
Crossref
Crossref
Katherine R. Marks, Joshua A. Lile, William W. Stoops, Paul E. A. Glaser, Lon R. Hays & Craig R. Rush. (2016) Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Journal of Clinical Psychopharmacology 36:3, pages 213-221.
Crossref
Crossref
Brian Kidd, Ed Day & John Strang. (2016) What matters is more than just the choice of pharmaceutical agent. Addiction 111:5, pages 779-781.
Crossref
Crossref
B. Levi Bolin, William W. Stoops, Jeremy P. Sites & Craig R. Rush. (2016) Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals. Journal of Addiction Medicine 10:3, pages 156-165.
Crossref
Crossref
Farzin Rezaei, Maryam Emami, Shakiba Zahed, Mohammad-Javad Morabbi, Mohammadhadi Farahzadi & Shahin Akhondzadeh. (2015) Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial. DARU Journal of Pharmaceutical Sciences 23:1.
Crossref
Crossref
Theodore K. Gideonse. (2015) Pride, Shame, and the Trouble with Trying to Be Normal. Ethos 43:4, pages 332-352.
Crossref
Crossref
Mehrdad Salehi, Alireza Emadossadat, Gholam Reza Kheirabadi, Mohammad Reza Maracy & Mohammad Reza Sharbafchi. (2015) The Effect of Buprenorphine on Methamphetamine Cravings. Journal of Clinical Psychopharmacology 35:6, pages 724-727.
Crossref
Crossref
Daniele Caprioli, Marco Venniro, Tamara Zeric, Xuan Li, Sweta Adhikary, Rajtarun Madangopal, Nathan J. Marchant, Federica Lucantonio, Geoffrey Schoenbaum, Jennifer M. Bossert & Yavin Shaham. (2015) Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model. Biological Psychiatry 78:7, pages 463-473.
Crossref
Crossref
Lara A Ray, Spencer Bujarski, Kelly E Courtney, Nathasha R Moallem, Katy Lunny, Daniel Roche, Adam M Leventhal, Steve Shoptaw, Keith Heinzerling, Edythe D London & Karen Miotto. (2015) The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology 40:10, pages 2347-2356.
Crossref
Crossref
Mario E. Alburges, Amanda J. Hoonakker, Nathaniel M. Cordova, Christina M. Robson, Lisa M. McFadden, Amber L. Martin & Glen R. Hanson. (2015) Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse 69:8, pages 396-404.
Crossref
Crossref
Kimberly R. Urban & Wen-Jun Gao. (2012) Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain. Journal of Attention Disorders 19:7, pages 603-619.
Crossref
Crossref
Andrew C. Harris, Mark G. LeSage, David Shelley, Jennifer L. Perry, Paul R. Pentel & S. Michael Owens. (2015) The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats. PLOS ONE 10:3, pages e0118787.
Crossref
Crossref
Ming D Li, Ju Wang, Tianhua Niu, Jennie Z Ma, Chamindi Seneviratne, Nassima Ait-Daoud, Jim Saadvandi, Rana Morris, David Weiss, Jan Campbell, William Haning, David J Mawhinney, Denis Weis, Michael McCann, Christopher Stock, Roberta Kahn, Erin Iturriaga, Elmer Yu, Ahmed Elkashef & Bankole A Johnson. (2014) Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction. BMC Medical Genomics 7:1.
Crossref
Crossref
Walter Ling, Linda Chang, Maureen Hillhouse, Alfonso Ang, Joan Striebel, Jessica Jenkins, Jasmin Hernandez, Mary Olaer, Larissa Mooney, Susan Reed, Erin Fukaya, Shannon Kogachi, Daniel Alicata, Nataliya Holmes & Asher Esagoff. (2014) Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction 109:9, pages 1489-1500.
Crossref
Crossref
Paolo Mannelli, Li‐Tzy Wu & Kathleen T. Brady. 2014. Substance Use and Older People. Substance Use and Older People
273
294
.
Ghassem Attarzadeh-Yazdi, Reza Arezoomandan & Abbas Haghparast. (2014) Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry 53, pages 142-148.
Crossref
Crossref
Katherine R. Marks, Joshua A. Lile, William W. Stoops & Craig R. Rush. (2014) Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Psychopharmacology 231:14, pages 2741-2750.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Clara Pérez-Mañá, Xavier Castells, Marta Torrens, Dolors Capellà & Magi Farre. (2013) Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Guibin Wang, Jie Shi, Na Chen, Lingzhi Xu, Jiali Li, Peng Li, Yan Sun & Lin Lu. (2013) Effects of Length of Abstinence on Decision-Making and Craving in Methamphetamine Abusers. PLoS ONE 8:7, pages e68791.
Crossref
Crossref
Sarah J. Baracz & Jennifer L. Cornish. (2013) Oxytocin modulates dopamine-mediated reward in the rat subthalamic nucleus. Hormones and Behavior 63:2, pages 370-375.
Crossref
Crossref
REBECCA MCKETIN, ADRIAN J. DUNLOP, ROHAN M. HOLLAND, RACHEL A. SUTHERLAND, AMANDA L. BAKER, ALLISON M. SALMON & SUSAN L. HUDSON. (2012) Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia. Drug and Alcohol Review 32:1, pages 80-87.
Crossref
Crossref
Andy C Dean, Stephanie M Groman, Angelica M Morales & Edythe D London. (2012) An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans. Neuropsychopharmacology 38:2, pages 259-274.
Crossref
Crossref
C. D. Gipson & P. W. Kalivas. 2012. Drug Discovery for Psychiatric Disorders. Drug Discovery for Psychiatric Disorders
357
383
.
Kristin M. Alvers, Joshua S. Beckmann, Guangrong Zheng, Peter A. Crooks, Linda P. Dwoskin & Michael T. Bardo. (2012) The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats. Psychopharmacology 224:2, pages 255-262.
Crossref
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Crossref
Tong H. Lee, Steven T. Szabo, J. Corey Fowler, Paolo Mannelli, O. Barry Mangum, Wayne F. Beyer, Ashwin Patkar & William C. Wetsel. (2012) Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: A novel treatment strategy. Drug and Alcohol Dependence 124:1-2, pages 11-18.
Crossref
Crossref
Yu-Lin Chao, Hwei-Hsien Chen & Chia-Hsiang Chen. (2012) Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice. Brain Stimulation 5:3, pages 393-401.
Crossref
Crossref
R. De La GarzaIIII, T.F. Newton, C.N. Haile, J.H. Yoon, C.S. Nerumalla, J.J. MahoneyIIIIII & A. Aziziyeh. (2012) Rivastigmine reduces “likely to use methamphetamine” in methamphetamine-dependent volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry 37:1, pages 141-146.
Crossref
Crossref
Marek Schwendt, Carmela M. Reichel & Ronald E. See. (2012) Extinction-Dependent Alterations in Corticostriatal mGluR2/3 and mGluR7 Receptors following Chronic Methamphetamine Self-Administration in Rats. PLoS ONE 7:3, pages e34299.
Crossref
Crossref
Kevin D Lominac, Arianne D Sacramento, Karen K Szumlinski & Tod E Kippin. (2011) Distinct Neurochemical Adaptations Within the Nucleus Accumbens Produced by a History of Self-Administered vs Non-Contingently Administered Intravenous Methamphetamine. Neuropsychopharmacology 37:3, pages 707-722.
Crossref
Crossref
G.R. Hanson, A.J. Hoonakker, M.E. Alburges, L.M. McFadden, C.M. Robson & P.S. Frankel. (2012) Response of limbic neurotensin systems to methamphetamine self-administration. Neuroscience 203, pages 99-107.
Crossref
Crossref
J. Graff‐Radford, J. L. Whitwell, Y. E. Geda & K. A. Josephs. (2011) Clinical and imaging features of Othello’s syndrome. European Journal of Neurology 19:1, pages 38-46.
Crossref
Crossref
Joshua A. Lile, William W. Stoops, Paul E.A. Glaser, Lon R. Hays & Craig R. Rush. (2011) Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug and Alcohol Dependence 119:3, pages 187-193.
Crossref
Crossref
Amy A. Herrold, Robin M. Voigt & T. Celeste Napier. (2011) Brain region-selective cellular redistribution of mGlu5 but not GABAB receptors following methamphetamine-induced associative learning. Synapse 65:12, pages 1333-1343.
Crossref
Crossref
Craig R. Rush, William W. Stoops, Joshua A. Lile, Paul E.A. Glaser & Lon R. Hays. (2011) Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacology Biochemistry and Behavior 100:1, pages 40-47.
Crossref
Crossref
Craig R. Rush, Andrea R. Vansickel & William W. Stoops. 2011. Drug Discrimination. Drug Discrimination
431
461
.
Tomoko Yoshimura, Hinako Usui, Nagahide Takahashi, Akira Yoshimi, Shinichi Saito, Branko Aleksic, Hiroshi Ujike, Toshiya Inada, Mitsuhiko Yamada, Naohisa Uchimura, Nakao Iwata, Ichiro Sora, Masaomi Iyo & Norio Ozaki. (2011) Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:5, pages 1268-1272.
Crossref
Crossref
Craig R. Rush, William W. Stoops, Joshua A. Lile, Paul E. A. Glaser & Lon R. Hays. (2010) Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology 214:3, pages 665-674.
Crossref
Crossref
Paul S. Frankel, Amanda J. Hoonakker, Mario E. Alburges, Jacob W. McDougall, Lisa M. McFadden, Annette E. Fleckenstein & Glen R. Hanson. (2011) Effect of Methamphetamine Self-Administration on Neurotensin Systems of the Basal Ganglia. Journal of Pharmacology and Experimental Therapeutics 336:3, pages 809-815.
Crossref
Crossref
Hideaki Kobayashi, Hiroshi Ujike, Nakao Iwata, Toshiya Inada, Mitsuhiko Yamada, Yoshimoto Sekine, Naohisa Uchimura, Masaomi Iyo, Norio Ozaki, Masanari Itokawa & Ichiro Sora. (2010) The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population. Behavioral and Brain Functions 6:1.
Crossref
Crossref
Dean S. Carson, Glenn E. Hunt, Adam J. Guastella, Lachlan Barber, Jennifer L. Cornish, Jonathon C. Arnold, Aurelie A. Boucher & Iain S. McGregor. (2010) Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology 15:4, pages 448-463.
Crossref
Crossref
Todd Zorick, Liam Nestor, Karen Miotto, Catherine Sugar, Gerhard Hellemann, Graham Scanlon, Richard Rawson & Edythe D. London. (2010) Withdrawal symptoms in abstinent methamphetamine‐dependent subjects. Addiction 105:10, pages 1809-1818.
Crossref
Crossref
Karla S. Frohmader, Katherine L. Bateman, Michael N. Lehman & Lique M. Coolen. (2010) Effects of methamphetamine on sexual performance and compulsive sex behavior in male rats. Psychopharmacology 212:1, pages 93-104.
Crossref
Crossref
Erin L. Winstanley, Shannon K. Bolon & Marc Fishman. 2010. Addictive Disorders in Medical Populations. Addictive Disorders in Medical Populations
575
601
.
Meadow M. Good, Ido Solt, Joann G. Acuna, Siegfried Rotmensch & Matthew J. Kim. (2010) Methamphetamine Use During Pregnancy. Obstetrics & Gynecology 116:2, pages 330-334.
Crossref
Crossref
Grant Colfax, Glenn-Milo Santos, Priscilla Chu, Eric Vittinghoff, Andreas Pluddemann, Suresh Kumar & Carl Hart. (2010) Amphetamine-group substances and HIV. The Lancet 376:9739, pages 458-474.
Crossref
Crossref
Laurent Karila, Aviv Weinstein, Henri‐Jean Aubin, Amine Benyamina, Michel Reynaud & Steven L. Batki. (2010) Pharmacological approaches to methamphetamine dependence: a focused review. British Journal of Clinical Pharmacology 69:6, pages 578-592.
Crossref
Crossref
Karla S. Frohmader, Kyle K. Pitchers, Margaret E. Balfour & Lique M. Coolen. (2010) Mixing pleasures: Review of the effects of drugs on sex behavior in humans and animal models. Hormones and Behavior 58:1, pages 149-162.
Crossref
Crossref
K.S. Frohmader, J. Wiskerke, R.A. Wise, M.N. Lehman & L.M. Coolen. (2010) Methamphetamine acts on subpopulations of neurons regulating sexual behavior in male rats. Neuroscience 166:3, pages 771-784.
Crossref
Crossref
Frank Barile. 2010. Clinical Toxicology. Clinical Toxicology
164
182
.
Steven B. Harrod & M. Lee Van Horn. (2009) Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats. Pharmacology Biochemistry and Behavior 94:2, pages 296-304.
Crossref
Crossref
Johannes W. Hell. (2009) Hooked on the D3 Receptor: CaMKII's New Addiction. Neuron 61:3, pages 335-336.
Crossref
Crossref
Didier Jutras-AswadM.D. M. ScM.D. M. Sc, Julie BruneauM.D. M. ScM.D. M. Sc & Yasmin L. HurdPh. D.Ph. D.. (2010) Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention. Drogues, santé et société 8:2, pages 27-73.
Crossref
Crossref
Langtian Yuan, Jin-Soo Seo, Nam Sook Kang, Shahar Keinan, Sarah E. Steele, Gregory A. Michelotti, William C. Wetsel, David N. Beratan, Young-Dae Gong, Tong H. Lee & Jiyong Hong. (2009) Identification of 3-hydroxy-2-(3-hydroxyphenyl)-4H-1-benzopyran-4-ones as isoform-selective PKC-ζ inhibitors and potential therapeutics for psychostimulant abuse. Molecular BioSystems 5:9, pages 927.
Crossref
Crossref